Publication Type : Journal Article
Publisher : Antibiotics
Source : Antibiotics, 2021, 10(11),1308, doi: 10.3390/antibiotics10111308.
Url : https://pubmed.ncbi.nlm.nih.gov/34827246/
Keywords : COVID-19; antifungal; diabetes; diagnosis; mucormycosis; nanotechnology.
Campus : Kochi
School : School of Pharmacy
Year : 2021
Abstract : The COVID-19 infection caused by the new SARS-CoV-2 virus has been linked to a broad spectrum of symptoms, from a mild cough to life-threatening pneumonia. As we learn more about this unusual COVID-19 epidemic, new issues are emerging and being reported daily. Mucormycosis, also known as zygomycosis or phycomycosis, causes severe fungal illness to individuals with a weakened immune system. It is a devastating fungal infection, and the most frequent kind is the rhino cerebral type. As a devastating second wave of COVID-19 sweeps India, doctors report several instances involving a strange illness-sometimes known as the "black fungus"-among returning and recovered COVID-19 patients. This paper analyzes the existing statistical data to address the severity of prevalence and further notes the nano-based diagnostic parameters, clinical presentations, its connection with other conditions like diabetes, hypertension, and GI disorders, and the importance of anti-fungal therapy in treating the same. Anti-fungal therapies, as well as surgical interventions, are currently used for the treatment of the disease. Proper and timely diagnosis is necessary, along with the reduction in the spread of COVID-19. From the review, it was found that timely pharmacologic interventions and early diagnosis by using a nano-based diagnostic kit can help control the disease. Additionally, this paper provides novel information about the nanotechnology approaches such as fungal detection biosensors, nucleic acids-based testing, point-of-care tests, and galactomannans detection, in the diagnosis of mucormycosis, and thereby reinforces the need for further research on the topic.
Cite this Research Publication : Asdaq, S.M.B., Rajan, A., Damodaran, A., Alrashed, A.A., Imran, M. Identifying mucormycosis severity in Indian COVID-19 patients: A nano-based diagnosis and the necessity for critical therapeutic intervention, Antibiotics, 2021, 10(11), 1308, doi: 10.3390/antibiotics10111308.